Acadia Pharmaceuticals stock gets $23 price target from Oppenheimer on CHMP reversal

The probe comes after the Commodity Futures Trading Commission and the Department of Justice dropped previous inquiries into Polymarket last July.

The pivot into physical AI grows On Semi's addressable market by an additional $30 billion, the company said.